| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/13/1996 | WO1996017868A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | WO1996017622A1 Antibodies which inhibit the binding of thrombin to platelets |
| 06/13/1996 | CA2207262A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | CA2206664A1 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 06/13/1996 | CA2206640A1 Human vascular ibp-like growth factor |
| 06/13/1996 | CA2206488A1 Cytokine designated lerk-7 |
| 06/13/1996 | CA2206471A1 Monoclonal antibody fragments having immunosuppressant activity |
| 06/13/1996 | CA2206321A1 Inhibition of glial cell proliferation |
| 06/12/1996 | EP0716146A2 A novel stem cell marker protein, antibodies thereto, compositions thereof and nucleotide sequences encoding said protein |
| 06/12/1996 | EP0716095A1 Method for quantitative determination of fas antigen |
| 06/12/1996 | EP0715653A1 Humanised antibodies |
| 06/12/1996 | EP0715522A1 Antibody-based treatment of hiv infection |
| 06/12/1996 | EP0573552B1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias |
| 06/12/1996 | EP0538353B1 Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
| 06/12/1996 | EP0463151B1 Generation of xenogeneic antibodies |
| 06/12/1996 | CN1124501A Anti-EGFR single-chain Fvs and anti-EGFR antibodies |
| 06/12/1996 | CN1124491A Inhibitor of stem cell proliferation and uses thereof |
| 06/12/1996 | CN1124456A Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 06/12/1996 | CN1032019C Process for recombinant biocides using organisms |
| 06/11/1996 | US5525717 Support-bound nucletide probe for neisseria gonorrhoeae |
| 06/11/1996 | US5525526 Converting to derivative that is used to raise antibody |
| 06/11/1996 | US5525519 Precipitating with a ph adjusted solution of polyoxyethylene glycol and polyvinylpyrrolidone |
| 06/11/1996 | US5525508 Purified antigen derived from homogenizing nematodes, extracting and chromatographing on wheat-germ lectin sepharose column |
| 06/11/1996 | US5525502 DNA encoding chitin deacetylase |
| 06/11/1996 | US5525491 Serine-rich peptide linkers |
| 06/11/1996 | US5525487 DNA encoding I-CAM related protein |
| 06/11/1996 | US5525486 Genetic engineering |
| 06/11/1996 | US5525476 Determination of okadaic acid, dinophysistoxin-1 and dinophysistoxin-3 using monoclonal antibody specific to these diarrheal shellfish poisons |
| 06/11/1996 | US5525474 Immunoassay; linking the haptenic drug via its maleimide moiety and a sulfhydryl bridge to an immunogenic carrier to stimulate antibodies |
| 06/11/1996 | US5525342 Reovirus strain 2177 and vaccine containing same |
| 06/11/1996 | US5525339 Presence in circulating bodily fluids provides diagnostic mechanism to determine onset of cerebral amyloid plaque formation |
| 06/11/1996 | US5525337 Detecting tumor cells by removing tissue or fluid sample, reacting with antibody capable of binding to surface antigen, detecting presence of antibody-antigen complex |
| 06/11/1996 | EP0722489A4 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 06/11/1996 | CA2005950C Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein |
| 06/11/1996 | CA1338381C Minactivin - (plasminogen activator inhibitor-2) |
| 06/09/1996 | CA2164374A1 Method for quantitative determination of fas antigen |
| 06/07/1996 | CA2141708A1 Nucleotide sequences encoding a novel stem cell marker protein, amino acid sequences of the protein, methods for expressing the protein, a composition of isolated protein, and antibodies specific to the protein |
| 06/06/1996 | WO1996017078A1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 06/06/1996 | WO1996017065A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits |
| 06/06/1996 | WO1996017060A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 06/06/1996 | WO1996017058A1 Denatured low-density lipoprotein receptor |
| 06/06/1996 | WO1996017055A1 Carrier protein driven crystallization of a peptide or polypeptide |
| 06/06/1996 | WO1996016990A1 Humanized antibodies to cd38 |
| 06/06/1996 | WO1996016988A1 Reagents and processes for targeting mutant epidermal growth factor receptors |
| 06/06/1996 | WO1996016985A1 Passive transfer immune serum and method of making |
| 06/06/1996 | WO1996016979A1 Expressed chemokines, their production and uses |
| 06/06/1996 | WO1996016974A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 06/06/1996 | WO1996016673A1 Method of promoting an immune response with a bispecific antibody |
| 06/06/1996 | WO1996016668A1 Novel hedgehog-derived polypeptides |
| 06/06/1996 | WO1996016665A1 Cd40 associated proteins |
| 06/06/1996 | CA2207869A1 Method of promoting an immune response with a bispecific antibody |
| 06/06/1996 | CA2206610A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 06/06/1996 | CA2206534A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 06/06/1996 | CA2206441A1 Cd40 associated proteins |
| 06/06/1996 | CA2206113A1 Expressed chemokines, their production and uses |
| 06/06/1996 | CA2204920A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids for coding for the same and use thereof in diagnostic and prophylactic methods and kits |
| 06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
| 06/05/1996 | EP0714665A2 Osteogenic devices |
| 06/05/1996 | EP0714512A1 Marking of products to establish identity and source |
| 06/05/1996 | EP0714511A1 Methods of detecting and combating disorders of the central nervous system |
| 06/05/1996 | EP0714510A1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/05/1996 | EP0714443A1 Detection and prevention of mycoplasma hominis infection |
| 06/05/1996 | EP0714440A1 T cell epitopes of ryegrass pollen allergen |
| 06/05/1996 | EP0714439A1 Recombinant humanized anti-human immunodeficiency virus antibody |
| 06/05/1996 | EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 06/05/1996 | EP0714410A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 06/05/1996 | EP0714409A1 Antibodies |
| 06/05/1996 | EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 06/05/1996 | EP0714401A1 A novel prostate/colon tumor suppressor gene located on human chromosome 8 |
| 06/05/1996 | EP0714399A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 06/05/1996 | EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
| 06/05/1996 | EP0714290A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 06/05/1996 | EP0497825B1 Anti-viral material |
| 06/05/1996 | EP0312542B1 Gamma, delta t cell receptor and methods for detection |
| 06/04/1996 | US5523393 BCL-2 proteins |
| 06/04/1996 | US5523290 Antiproliferation factor |
| 06/04/1996 | US5523229 Binding partner having affinity for carboxy-terminal region |
| 06/04/1996 | US5523210 Breaking disulfide bonds linking l-h half molecules, splitting each antibody or fragment into two identical reduced half-molecule, derivatizing one with dithiol activator, combining activated and reduced half molecules |
| 06/04/1996 | US5523209 Culturing a cell expressing a chimeric integrin and contacting with ligand that binds to reporter integrin only when activated |
| 06/04/1996 | US5523089 Borrelia antigen |
| 06/04/1996 | US5523085 Monoclonal antibody in destruction of small cell lung carcinoma |
| 06/04/1996 | CA2054551C Monoclonal antibodies to mite allergen and the use thereof |
| 05/30/1996 | WO1996016171A1 Toxins from the wasp bracon hebetor |
| 05/30/1996 | WO1996016169A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 05/30/1996 | WO1996016087A1 G-protein coupled receptor |
| 05/30/1996 | WO1996016082A1 Novel polypeptides |
| 05/30/1996 | WO1996016075A1 Antibiotic cryptdin peptides and methods of their use |
| 05/30/1996 | WO1996015806A1 Human choline acetyltransferase |
| 05/30/1996 | WO1996012807A3 Hepatitis e virus antigens and uses therefor |
| 05/30/1996 | WO1996010427A3 Cellular attachment to trans-epithelial appliances |
| 05/30/1996 | DE19541284A1 Verfahren zur Immunmodulation Methods for immunomodulation |
| 05/30/1996 | CA2204524A1 Toxins from the wasp bracon hebetor |
| 05/30/1996 | CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 05/29/1996 | EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY |
| 05/29/1996 | EP0713496A1 Fibrin-targeted inhibitors of thrombin |
| 05/29/1996 | EP0713398A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS |
| 05/29/1996 | EP0636171A4 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells. |
| 05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/29/1996 | EP0469065B1 Recombinant antibody-toxin fusion protein |
| 05/29/1996 | EP0431129B1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |